U. Rahmsdorf

697 citations
10 papers · 607 indexed · h-index 8
Topics
Virus-based gene therapy research (4 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)interferon and immune responses (2 papers)

In The Last Decade

U. Rahmsdorf

10 papers receiving 504 citations

Peers

U. Rahmsdorf
Comparison fields: 5 of 73
  • Molecular Biology 437
  • Genetics 246
  • Immunology 86
  • Oncology 74
  • Cancer Research 54
Replace V M Watt with:
V M Watt Canada
Irantzu Tato Spain
Per Henrik Guddal Norway
Marie‐Laure Curchod Switzerland
Jonathan M. Wojciak United States
A.D.M. van Mansfeld Netherlands
Alfonso Valencia Spain
Raul Salinas United States
J. Guhaniyogi United States
Philip Bernstein United States
U. Rahmsdorf relative to V M Watt Canada V M Watt's profile →
Citations per field
00.5×4.3×
V M Watt · 1×
Citations per year

Countries citing papers authored by U. Rahmsdorf

Since Specialization
Citations

This map shows the geographic impact of U. Rahmsdorf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Rahmsdorf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Rahmsdorf more than expected).

Fields of papers citing papers by U. Rahmsdorf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Rahmsdorf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Rahmsdorf. The network helps show where U. Rahmsdorf may publish in the future.

Co-authorship network of co-authors of U. Rahmsdorf

This figure shows the co-authorship network connecting the top 25 collaborators of U. Rahmsdorf. A scholar is included among the top collaborators of U. Rahmsdorf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Rahmsdorf. U. Rahmsdorf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 14
2 197
3 3
4 53
5 10
6
DNA mediated transfer and fate of a proviral gene of mouse mammary tumor virus in cultured cells.
1
7 145
8 29
9 16
10 139

About U. Rahmsdorf

U. Rahmsdorf is a scholar working on Immunology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 10 papers that have together received 607 indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Genetics (246 citations), Molecular Biology (437 citations) and Molecular Medicine (29 citations). U. Rahmsdorf has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Nicholas A. Kennedy, Peter Herrlich, Bernd Groner, Nancy E. Hynes, Helmut Ponta, Hans J. Rahmsdorf, Marita Büscher, Harald König, Axel H. Schönthal and Mark Achtman. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026